QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kelner, K. L. Articles by Pollard, H. B. Search for Related Content PubMed PubMed Citation Articles by Kelner, K. L. Articles by Pollard, H. B.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 5, 2161-2168, Copyright © 1985 by Society for Neuroscience

ARTICLE

Glucocorticoid receptors and regulation of phenylethanolamine-N- methyltransferase activity in cultured chromaffin cells

KL Kelner and HB Pollard

Glucocorticoids are known to regulate the enzyme phenylethanolamine-N- methyltransferase (PNMT) in the adrenal medulla of the rat and are thereby thought to control the synthesis of epinephrine. We have examined the details of this relationship in a simplified system, chromaffin cell primary cultures derived from bovine adrenal medulla. Cultured chromaffin cells were found to have a cytosolic, high affinity, saturable glucocorticoid-binding protein with the steroid specificity of a classical glucocorticoid receptor and a Kd of approximately 1 nM. Treatment of cultured cells with dexamethasone or hydrocortisone at any time up to 21 days in culture increased PNMT activity in the soluble fraction of the cell. The concentration of hormone required to produce a half-maximal response was 10 nM dexamethasone when cells were cultured in the presence of 5% fetal calf serum, or 1 nM in a defined serum-free medium. These dose-response relationships are consistent with mediation of this effect by the glucocorticoid receptor. Unexpectedly, however, the glucocorticoid- induced increment in PNMT activity was not inhibited by cycloheximide at concentrations up to 50 microM, and an acceleration of protein synthesis by insulin treatment did not augment the glucocorticoid effect on PNMT. Treatment of the cells with dexamethasone (100 microM) prevented the decline in the epinephrine-to-norepinephrine ratio seen over time in culture, an effect consistent with increased PNMT activity. However, there was no effect of dexamethasone on the ability of the cells to secrete catecholamines in response to stimulation with high KCl or 30 microM nicotine.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. Xu, K. S. Tang, V. B. Lu, C. P. Weerasinghe, A. Tse, and F. W. Tse Maintenance of quantal size and immediately releasable granules in rat chromaffin cells by glucocorticoid Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1122 - C1133. [Abstract] [Full Text] [PDF]

				G. Eisenhofer, M. M. Walther, T.-T. Huynh, S.-T. Li, S. R. Bornstein, A. Vortmeyer, M. Mannelli, D. S. Goldstein, W. M. Linehan, J. W. M. Lenders, et al. Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1999 - 2008. [Abstract] [Full Text]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help